Home > > > Report Detail

Global Thrombocytopenia (Immune & Chemotherapy-induced) Market: Insights, Trends and Forecast (2019-2023)

Publisher Name :
Date: 06-Sep-2019
No. of pages: 95
Inquire Before Buying

The global immune thrombocytopenia (ITP) market is expected to reach 2.27 billion in 2023, growing at a CAGR of 5.82%, for the duration spanning 2019-2023. The factors such as, rising healthcare expenditures, growing female population, rising prevalence of arthritis, increasing incidences of hepatitis C and new cases of diagnosed cancer would drive the growth of the market. However, market growth would be challenged by the lethargic drug approval process, side effects associated with available thrombocytopenia drugs and the availability of alternative treatment options. A few notable trends include, novel drug development for thrombocytopenia, increasing number of awareness programs against thrombocytopenia, and increasing preferences for biosimilars.

The global thrombocytopenia market would witness considerable growth in coming years, due to the rising prevalence of thrombocytopenia and associated risk factors. The most common type of thrombocytopenia is ITP, which is highly prevalent in patients with rheumatoid arthritis. Whereas, CIT (Chemotherapy-Induced Thrombocytopenia) occurs in patients with cancer, due to the involvement of chemotherapy and radiation treatment. Thrombocytopenia in patients with CLD is growing rapidly with an increase in incidences of HCV infections among them.

The fastest growing regional market is the U.S., owing to the high prevalence of thrombocytopenia in patients with cancer as well as chronic liver diseases. Moreover, rising awareness about the symptoms and causes of thrombocytopenia among people, through various campaigns and the FDA approvals of various novel drugs for the treatment of thrombocytopenia would drive considerable growth in the global thrombocytopenia market.

Scope of the report:


  • The report provides a comprehensive analysis of the global thrombocytopenia (Immune and Chemotherapy-induced) market.

  • The major regional market (the U.S.) has been analyzed.

  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

  • The competitive landscape of the market, along with the company profiles of leading players (Novartis AG, Merck and Co., CSL Limited, Amgen Pharmaceuticals, Horizon Therapeutics and Rigel Pharmaceuticals) are also presented in detail.


Key Target Audience:


  • Thrombocytes Drugs Manufacturers

  • Chemical Suppliers

  • End Users (Hospital, Medical Centers, Clinical Institutes)

  • Healthcare Consulting Firms

  • Investment Banks

  • Government Bodies & Regulating Authorities

Global Thrombocytopenia (Immune & Chemotherapy-induced) Market: Insights, Trends and Forecast (2019-2023)

Table of Contents

1. Overview
1.1 Introduction
1.2 Causes of Thrombocytopenia
1.3 Symptoms of Thrombocytopenia
1.4 Diagnosis of Thrombocytopenia
1.5 Treatment of Thrombocytopenia
1.6 Pathophysiology of Thrombocytopenia

2. Global Thrombocytopenia Market
2.1 Global ITP Market
2.1.1 Global ITP Market Forecast by Value
2.1.2 Global ITP Total Patient Volume Forecast
2.1.3 Global ITP Total Patient Volume Forecast by Region
2.1.4 Global ITP Treated Patient Volume Forecast
2.1.5 Global ITP Treated Patient Volume Forecast by Region
2.2 Global CIT Market
2.2.1 Global CIT Total Patient Volume Forecast
2.2.2 Global CIT Total Patient Volume Forecast by Region
2.2.3 Global CIT Treated Patient Volume Forecast
2.2.4 Global CIT Treated Patient Volume Forecast by Region

3. Regional Thrombocytopenia Market
3.1 The U.S.
3.1.1 The U.S. ITP Total Patient Volume Forecast
3.1.2 The U.S. ITP Treated Patient Volume Forecast
3.1.3 The U.S. Doptelet ITP Treated Patient Volume Forecast
3.1.4 The U.S. CIT Total Patient Volume Forecast
3.1.5 The U.S. CIT Treated Patient Volume Forecast
3.1.6 The U.S. Doptelet CIT Treated Patient Volume Forecast
3.1.7 The U.S. CLD Patient Volume Forecast
3.1.8 The U.S. CLD Patient Volume with Severe Thrombocytopenia Forecast
3.1.9 The U.S. CLD Treated Patient Volume with Severe Thrombocytopenia Forecast
3.2 ROW (Rest of World)
3.2.1 ROW ITP Total Patient Volume Forecast
3.2.2 ROW ITP Treated Patient Volume Forecast
3.2.3 ROW CIT Total Patient Volume Forecast
3.2.4 ROW CIT Treated Patient Volume Forecast

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising HealthCare Expenditure
4.1.2 Growing Female Population
4.1.3 Rising Prevalence of Arthritis
4.1.4 Increasing Incidences of Hepatitis C
4.1.5 New Cases of Diagnosed Cancer
4.2 Key Trends & Development
4.2.1 Novel Drug Development for Thrombocytopenia
4.2.2 Increasing Number of Awareness Programs about Thrombocytopenia
4.2.3 Increase in Pharmaceutical R&D Expenditures
4.2.4 Increasing Preference for Biosimilars
4.3 Challenges
4.3.1 Lethargic Drug Approval Process
4.3.2 Side Effects Associated With Available Thrombocytopenia Drugs
4.3.3 Availability of Alternative Treatment Options

5. Competitive Landscape
5.1 Global Market
5.1.1 Key Players – Available Drugs for Chronic Thrombocytopenia
5.1.2 Key Players – R&D Comparison
5.1.3 Key Players - Revenue Comparison
5.1.4 Key Players – Market Cap Comparison

6. Company Profiles
6.1 Novartis AG
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Merck & Co.
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Amgen Inc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 CSL Limited
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies
6.5 Horizon Therapeutics
6.5.1 Business Overview
6.5.2 Financial Overview
6.5.3 Business Strategies
6.6 Rigel Pharmaceuticals
6.6.1 Business Overview
6.6.2 Financial Overview
6.6.3 Business Strategies

List of Tables

Causes of Thrombocytopenia
The U.S. Diagnosed Arthritis Population (2000-2020)
Hepatitis C Population in Major Regions (2018)
Global New Cases of Diagnosed Cancer (2018)
Key Players - Available Drugs for Chronic Thrombocytopenia
Key Players - Revenue Comparison (2018)
Key Players - Market Cap Comparison (2019)

List of Figures

Symptoms of Thrombocytopenia
Diagnosis of Thrombocytopenia
Treatment of Thrombocytopenia
Global ITP Market Forecast by Value (2019-2023)
Global Total ITP Total Patient Volume Forecast (2019-2023)
Global ITP Total Patient Volume Forecast by Region (2023)
Global ITP Treated Patient Volume Forecast (2019-2023)
Global ITP Treated Patient Volume Forecast by Region (2023)
Global CIT Total Patient Volume Forecast (2019-2023)
Global CIT Total Patient Volume Forecast by Region (2018/2023)
Global CIT Treated Patient Volume Forecast (2018-2023)
Global CIT Treated Patient Volume Forecast by Region (2018/2023)
The U.S. ITP Total Patient Volume Forecast (2019-2023)
The U.S. ITP Treated Patient Volume Forecast (2019-2023)
The U.S. Doptelet ITP Treated Patient Volume Forecast (2019-2023)
The U.S. CIT Total Patient Volume Forecast (2018-2023)
The U.S. CIT Treated Patient Volume Forecast (2018-2023)
The U.S. Doptelet CIT Treated Patient Volume Forecast (2021-2026)
The U.S. CLD Patient Volume Forecast (2018-2023)
The U.S. CLD Patient Volume with Severe Thrombocytopenia Forecast (2018-2023)
The U.S. CLD Treated Patient Volume with Severe Thrombocytopenia Forecast (2018-2023)
ROW ITP Total Patient Volume Forecast (2019-2023)
ROW ITP Treated Patient Volume Forecast (2019-2023)
ROW CIT Total Patient Volume Forecast (2018-2023)
ROW CIT Treated Patient Volume Forecast (2018-2023)
Global HealthCare Expenditure Per Capita (2014-2018)
Global Female Population (2014-2018)
Novel Drug Development for Thrombocytopenia (2018)
Awareness Programs about Thrombocytopenia (2018)
Global Pharmaceutical R&D Expenditures (2014-2018)
Drugs Approval Process
Key Players - R&D Comparison (2017-2018)
Novartis AG Net Sales and Net Income (2014-2018)
Novartis AG Net Sales by Segment (2018)
Novartis AG Net Sales by Regions (2018)
Merck & Co. Sales and Net Income (2014-2018)
Merck & Co. Sales by Segment (2018)
Merck & Co. Sales by Regions (2018)
Amgen Inc. Total Revenue and Net Income (2014-2018)
Amgen Inc. Total Revenue by Segment (2018)
Amgen Inc. Total Revenue by Regions (2018)
CSL Limited Total Operating Revenue and Net Profit (2014-2018)
CSL Limited Total Operating Revenue by Segment (2018)
CSL Limited Total Operating Revenue by Regions (2018)
Horizon Therapeutics Net Sales and Net Loss (2014-2018)
Horizon Therapeutics Net Sales by Segment (2018)
Horizon Therapeutics Net Sales by Regions (2018)
Rigel Pharmaceuticals Total Revenue and Net Loss (2014-2018)
Rigel Pharmaceuticals Total Revenue by Divisions (2018)

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs